By using our website, you agree to the use of our cookies.

Employees and Board of Directors

Employees

Göran Nordström

Göran Nordström

Founding Partner / Chief Executive Officer

Over 30 years of experience in leading financial positions.
Education: LL.B., Bachelor of Laws, University of Stockholm, Financial Analyst, IFL.

Henrik Rhenman

Henrik Rhenman

Founding Partner / Chief Investment Officer

Over 25 years of experience in portfolio management.
Education: Biochemist, Royal Institute of Technology, B.Sc., Stockholm School of Economics.

Susanna Urdmark

Susanna Urdmark

Portfolio Manager (RHE L/S)

Employed at Rhenman & Partners since: 2017. Over 20 years of experience in the sector.
Education: B.Sc., Stockholm School of Economics.

Kaspar Hållsten

Kaspar Hållsten

Analyst (RHE L/S)

Employed at Rhenman & Partners since: 2017.
Education: Business Administration, Finance, B.Sc., Stockholm Business School.

Staffan Knafve

Staffan Knafve

Portfolio Manager (RGO L/S)

Affiliated to Rhenman & Partners since: 2012.
Over 25 years of experience in the stock market.
Education: LL.B., Bachelor of Laws, University of Stockholm.

Hugo Schmidt

Hugo Schmidt

Trainee

Employed at Rhenman & Partners since: 2019.
Education: Stockholm School of Economics.

Carl Grevelius

Carl Grevelius

Founding Partner / Head of Investor Relations

Over 20 years of international fund and equity experience.
Education: B.Sc., Uppsala University.

Anders Grelsson

Anders Grelsson

Investor Relations Sweden

Employed at Rhenman & Partners since: 2011.
Over 25 years of experience in financial management.

Camilla Hermansson

Camilla Hermansson

Assistant, Client Relations Sweden

Employed at Rhenman & Partners since: 2011.

Board of Directors

Professor Hans Wigzell

Professor Hans Wigzell

Chairman of the Board

Professor of Immunology, Karolinska Institutet. Former president of Karolinska Institutet, head of the Infectious Disease Institute, the State Bacteriological Laboratory and chair of Karolinska Institutet’s Nobel Committee. Member of the Royal Academy of Sciences and the Royal Swedish Academy of Sciences IVA. Total number of active board assignments: 4.

Birgitta Stymne Göransson

Birgitta Stymne Göransson

Director

M.Sc. in Chemistry/Biotechnology, Royal Institute of Technology (KTH), and MBA Harvard Business School. Board member Elekta AB, LEO Pharma A/S, Pandora A/S and Enea AB. Chairman of the Boards of BCB Medical Oy and MAG Interactive. Previously CEO of Memira Group, COO at Telefos, McKinsey Associate and Product manager at Gambro. Total number of active board assignments: 7

Håkan Åström

Håkan Åström

Director

Honorary Doctorate in Medicine and Bachelor of Science in Economics. Chair of Affibody Medical AB, PledPharma and 20 North Street (RP) AB. Former Chair of Swedish Orphan Biovitrum AB (SOBI), Orexo AB and Ferrosan AS. CEO of Pharmacia Kabi and Astra Pharmaceutical Ltd. Several other leading positions in the pharmaceutical industry Total number of board appointments: 6

Göran Nordström

Göran Nordström

Director

Law degree, Stockholm University, and Financial Analyst, IFL Founders and CEO, Rhenman & Partners. Former head of Private Banking, Kaupthing Bank Sweden. CEO, Carnegie Asset Management AB. CEO, Carnegie Pension Consulting. Vice President, Midland Montague Bank/HSBC. Portfolio manager, Handelsbanken Asset Management. Tax expert, County Administrative Board in Stockholm County. Total number of active board assignments: 3.

Henrik Rhenman

Henrik Rhenman

Director

Biochemist, Royal Institute of Technology and M.Sc., School of Business. Founder and Managing Director, Rhenman & Partners. Former Founder & CIO, Carnegie Healthcare Funds, Carnegie Investment Bank. CEO, Portfolio Manager, SG Cowen, Boston. Portfolio manager, SEB Pharmaceutical Fund. Head of Analysis, Hagströmer & Qviberg. Total number of active board assignments: 2.

Carl Grevelius

Carl Grevelius

Secretary

Bsc, Uppsala University. Founder and Head of Investor Relations, Rhenman & Partners. Former portfolio manager, Carnegie Investment Bank, Stockholm. Founder and portfolio manager, Absolute Plus, Zurich. Equity analyst, ABG Sundal Collier, London and Zurich. Portfolio Strategist, Fidelity Investments, Luxembourg and London.